Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Titel:
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Auteur:
Sunami, Kazutaka Ikeda, Takashi Huang, Shang-Yi Wang, Ming-Chung Koh, Youngil Min, Chang Ki Yeh, Su-Peng Matsumoto, Morio Uchiyama, Michihiro Iyama, Satoshi Shimazaki, Chihiro Lee, Jae Hoon Kim, Kihyun Kaneko, Hitomi Kim, Jin Seok Lin, Tung-Liang Campana, Frank Tada, Keisuke Iida, Shinsuke Suzuki, Kenshi